Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2017

Conditions

Pulmonary Infections

Interventions

DRUG

Dornase alfa

2.5 mg nebulized endotracheally every 12 hours for 7 days or until extubation

DRUG

Placebo

No therapy will be given to placebo arm

Trial Locations (2)

Georgetown University Hospital NICU, Washington D.C.

Georgetown University Hospital, Washington D.C.